CATALOGO DEI PRODOTTI DELLA RICERCA

MONACO, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.726
EU - Europa 12.833
AS - Asia 9.077
SA - Sud America 1.139
AF - Africa 190
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 8
Totale 38.024
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.490
RU - Federazione Russa 4.643
SG - Singapore 3.479
CN - Cina 3.033
GB - Regno Unito 2.788
IT - Italia 1.404
BR - Brasile 913
SE - Svezia 903
VN - Vietnam 720
HK - Hong Kong 713
FR - Francia 686
DE - Germania 624
IE - Irlanda 583
FI - Finlandia 559
KR - Corea 301
UA - Ucraina 177
CA - Canada 139
IN - India 139
BD - Bangladesh 135
TR - Turchia 93
AR - Argentina 86
BE - Belgio 84
JP - Giappone 84
ID - Indonesia 73
PL - Polonia 65
NL - Olanda 56
MX - Messico 55
NG - Nigeria 50
IQ - Iraq 48
ES - Italia 47
AU - Australia 45
AT - Austria 40
ZA - Sudafrica 40
EC - Ecuador 32
IR - Iran 30
VE - Venezuela 27
PK - Pakistan 25
UZ - Uzbekistan 24
SA - Arabia Saudita 23
CL - Cile 22
CO - Colombia 21
JO - Giordania 18
LT - Lituania 18
EG - Egitto 17
CH - Svizzera 16
IL - Israele 16
MA - Marocco 15
PH - Filippine 15
PY - Paraguay 14
TN - Tunisia 14
AZ - Azerbaigian 13
CZ - Repubblica Ceca 13
GR - Grecia 13
NO - Norvegia 13
HU - Ungheria 12
RO - Romania 11
DO - Repubblica Dominicana 10
LB - Libano 10
LV - Lettonia 10
NP - Nepal 10
BO - Bolivia 9
DZ - Algeria 9
HR - Croazia 9
AL - Albania 8
CR - Costa Rica 8
DK - Danimarca 8
KZ - Kazakistan 8
RS - Serbia 8
AE - Emirati Arabi Uniti 7
BG - Bulgaria 7
JM - Giamaica 7
OM - Oman 7
PE - Perù 7
TG - Togo 7
UY - Uruguay 7
KE - Kenya 6
KG - Kirghizistan 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
KH - Cambogia 5
NZ - Nuova Zelanda 5
TH - Thailandia 5
HN - Honduras 4
LA - Repubblica Popolare Democratica del Laos 4
LI - Liechtenstein 4
LU - Lussemburgo 4
MY - Malesia 4
PS - Palestinian Territory 4
PT - Portogallo 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BJ - Benin 3
BY - Bielorussia 3
CG - Congo 3
CI - Costa d'Avorio 3
EU - Europa 3
ML - Mali 3
Totale 37.974
Salva come PNG Salva come JPEG
Città #
Southend 2.318
Singapore 1.821
Ashburn 1.679
Chandler 1.605
Moscow 1.584
San Jose 1.238
Dallas 1.134
Jacksonville 1.130
Woodbridge 831
Ann Arbor 710
Hong Kong 702
Verona 603
Dublin 575
Beijing 535
Houston 499
The Dalles 418
New York 344
Council Bluffs 283
Los Angeles 276
Wilmington 248
Lawrence 232
Princeton 232
Jinan 224
Ho Chi Minh City 213
Nanjing 205
Helsinki 167
Buffalo 164
Hebei 152
Shenyang 145
Hanoi 137
Munich 119
Tianjin 113
Columbus 98
Santa Clara 96
Milan 92
São Paulo 91
Ningbo 87
Redondo Beach 87
Sindelfingen 86
Zhengzhou 81
Brussels 80
Changsha 80
Nanchang 77
Lancaster 76
Tokyo 74
Boardman 72
Haikou 72
Redmond 70
Turku 70
Montreal 67
Guangzhou 65
Dearborn 64
Seoul 59
Taizhou 59
Hangzhou 58
Orem 57
Seattle 57
Washington 55
Dong Ket 54
Chicago 53
Warsaw 53
Rome 52
Jakarta 51
Redwood City 51
London 50
Jiaxing 49
Falls Church 45
Taiyuan 44
Abuja 43
Denver 41
Istanbul 40
Brooklyn 39
Norwalk 39
Stockholm 39
Fairfield 38
Fuzhou 38
Chennai 37
San Francisco 36
Frankfurt am Main 35
Toronto 34
Haiphong 32
Rio de Janeiro 32
Bologna 31
Da Nang 30
Boston 29
Lanzhou 28
Nuremberg 27
Atlanta 24
Belo Horizonte 24
Lappeenranta 24
Paris 24
Amsterdam 23
Johannesburg 23
Phoenix 23
Adelaide 22
Falkenstein 22
Vienna 22
Clearwater 21
Tashkent 21
Auburn Hills 20
Totale 24.029
Salva come PNG Salva come JPEG
Nome #
Allelic origin of protease-sensitive and protease-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker Disease with the P102L mutation. 269
Increased levels of CSF heart-type fatty acid-binding protein and tau protein after aneurysmal subarachnoid hemorrhage. 266
Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy 263
La biopsia del nervo periferico. Indicazioni, metodiche e principali quadri patologici [Peripheral nerve biopsy. Indications, methods and principal pathological pictures] 261
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 261
A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome. 259
Acute inflammatory demyelinating polyneuropathy as a manifestation of chronic lymphoproliferative disorder of NK cells. 253
AUMENTATA ESPRESSIONE DEL GENE COX-2 NEL SANGUE PERIFERICO DI PAZIENTI CON ICTUS ISCHEMICO 253
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian Consensus Conference on Pain in Neurorehabilitation 246
Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples 245
Accuracy of diagnostic criteria for sporadic Creutzfeldt-Jakob disease among rapidly progressive dementia. 243
AZT-induced mitochondrial myopathy 238
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 238
Antisulfatide polyneuropathy: antibody-mediated complement attack on peripheral myelin 236
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 234
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 232
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 227
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 222
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 221
Clinical outcomes of secondary prevention strategies for young patients with cryptogenic stroke and patent foramen ovale 220
A 49-year-old man with neuropsychiatric symptoms followed by progressive cognitive decline. 219
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 213
[Hypertrophic neuropathies beginning in infancy: a study of 3 cases (author's transl)] 211
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 211
A test for Creutzfeldt-Jakob disease using nasal brushings. 211
A case of acute fulminant multiple sclerosis treated with alemtuzumab 211
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 211
Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma. 210
Brentuximab vedotin: axonal microtubule's Apollyon 209
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 209
Cognitive onset in multiple sclerosis 208
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 208
Molecular analysis of iatrogenic scrapie in Italy 207
Analysis of mammalian scrapie protein by novel monoclonal antibodies recognizing distinct prion protein glycoforms: an immunoblot and immunohistochemical study at the light and electron microscopic levels. 207
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 206
Time for a Consensus Conference on pain in neurorehabilitation 206
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder 206
Risk factors for post-polio syndrome among an Italian population: a case-control study. 205
Paroxysmal dysarthria-ataxia in remitting-relapsing Bickerstaff's-like encephalitis. 205
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events 205
Cytoskeletal changes in cultured human fibroblasts following exposure to 2,5-hexanedione 204
Lesione bilaterale della corteccia cingolata anteriore: studio polisonnografico ad autonomico di un caso. 204
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 204
Binding of monoclonal anti-myelin-associated glycoprotein antibodies to human foetal peripheral neurons in culture 202
Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies 202
Unusual case of solitary intraparenchymal brain plasmacytoma. 201
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 201
Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease 200
Intravenous immunoglobulin for post-polio syndrome: a randomized double-blind, placebo-controlled study 200
RFC1 AAGGG repeat expansion masquerading as Chronic Idiopathic Axonal Polyneuropathy 200
Adult-onset migraine-related ophthalmoplegia and omolateral fetal-type posterior cerebral artery. 199
Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping 198
High diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD 198
Iron loss of thalamic nuclei evaluated with quantitative susceptibility mapping is related to intrathecal macrophages activity and cortical pathology of multiple sclerosis 197
Neurosyphilis manifesting with rapidly progressive dementia: report of three cases. 195
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 195
Immunoaffinity reactors for prion protein qualitative analysis 194
The proteome: anno Domini 2002 193
Association of prolonged QTc interval with Takotsubo cardiomyopathy: A neurocardiac syndrome inside the mystery of the insula of Reil 191
Convergent pathological and ultrasound features in hereditary syndromic and non‐syndromic minifascicular neuropathy related to DHH 191
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 190
Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. 189
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 189
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 188
The dispersion of myocardial repolarization in ischemic stroke and intracranial hemorrhage 188
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 186
Neurodegeneration-associated proteins in human olfactory neurons collected by nasal brushing 186
Nervous system: subclinical target of SARS-CoV-2 infection 186
Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy 186
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 185
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report. 185
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 184
Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease 184
Epilepsy in multiple sclerosis: The role of temporal lobe damage 181
Cerebral amyloidoses: molecular pathways and therapeutic challenges 180
Spectral analysis of cardiovascular responses in POTS 179
Specific and surrogate cerebrospinal fluid markers in Creutzfeldt–Jakob Disease (chapter 17) 177
QTc Prolongation in Patients with Dementia and Mild Cognitive Impairment: Neuropsychological and Brain Imaging Correlations 177
Intraspecies transmission of BASE induces clinical dullness and amyotrophic changes 176
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 176
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 175
Response to Nagai et al. 175
Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson's disease 173
Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. 173
Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype 172
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 171
Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia 170
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 170
Sural nerve biopsy: current role and comparison with serum neurofilament light chain levels 170
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 170
Heart rate variability in patients with spinal cord injuries 169
pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease 169
Inherited neuroaxonal dystrophy in C6 deficient rabbits 168
T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy 168
Biochemical characterization of prions 168
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 168
Friedreich's ataxia. A light- and electron microscopic study of peripheral nerve biopsies 167
Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis 166
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 166
MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome 166
Totale 20.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.440
article - articoli 120.934
book - libri 0
conference - conferenze 2.939
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.567
Totale 256.880
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021124 0 0 0 0 0 0 0 0 0 0 0 124
2021/20222.251 193 765 20 275 50 110 32 111 65 67 149 414
2022/20234.226 306 483 379 745 384 971 35 307 432 22 103 59
2023/20242.063 80 163 179 215 272 467 78 120 19 129 218 123
2024/20255.162 277 357 226 840 259 195 240 259 802 301 430 976
2025/202615.352 1.085 871 1.134 2.333 3.892 1.052 1.363 808 1.216 916 289 393
Totale 38.329